Peptide Companion
Back to catalog
Peptide Companion
single
Anti-Aging
Vial: 20 mg

Chonluten (20 mg Vial)

Chonluten is a short bioregulatory tripeptide (Glu‑Asp‑Gly) studied for its effects on bronchopulmonary tissue and inflammatory pathways in monocyte/macrophage cell models. As a small peptide with poor oral stability, subcutaneous injection is the indicated parenteral route. This educational protocol presents a once‑daily subcutaneous approach using a practical dilution for clear insulin‑syringe measurements.

Detailed protocol below.

Dosing Schedule
WeekDaily Dose (mcg)Units (per injection) (mL)
Weeks 1–2250 mcg (0.25 mg)3.75 units (0.0375 mL)
Weeks 3–4500 mcg (0.5 mg)7.5 units (0.075 mL)
Weeks 5–61,000 mcg (1 mg)15 units (0.15 mL)
Weeks 7–81,500 mcg (1.5 mg)22.5 units (0.225 mL)
Weeks 9–102,000 mcg (2 mg)30 units (0.30 mL)
Weeks 11–123,000 mcg (3 mg)45 units (0.45 mL)
Weeks 13–144,000 mcg (4 mg)60 units (0.60 mL)
Weeks 15–164,000 mcg (4 mg)60 units (0.60 mL)
Supplies Needed
  • •Peptide Vials (Chonluten, 20 mg each):
  • •Insulin Syringes (U‑100):
  • •Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution.
  • •Alcohol Swabs: One for the vial stopper + one for the injection site each day.
References

  • Int J Mol Sci (2022)

    Peptides Regulating Proliferative Activity and Inflammatory Pathways in the Monocyte/Macrophage THP-1 Cell Line

    View source

  • Biomedicines (2025)

    Overcoming Oral Cavity Barriers for Peptide Delivery Using Advanced Pharmaceutical Techniques and Nano-Formulation Platforms

    View source

  • Sigma-Aldrich

    Peptide Handling Guide (storage, reconstitution, and stability recommendations)

    View source

  • CDC (Subcut Injection PDF)

    You Call the Shots: Subcutaneous Injection Technique

    View source

  • Signal Transduction and Targeted Therapy (2022)

    Therapeutic peptides: current applications and future directions

    View source

  • CDC

    Preventing Unsafe Injection Practices (clinical safety guidance)

    View source

  • WHO (2021)

    Guidance on preparation and administration of subcutaneous injections

    View source

  • NCBI Bookshelf

    Best practices for injection (asepsis, preparation, and administration)

    View source

  • Subcutaneous Drug Injection Review (PMC)

    Pharmacologic considerations of the subcutaneous route

    View source

  • Alzheimer’s Drug Discovery Foundation (2015)

    Epithalamin/Epithalon Evidence Summary (bioregulator peptide context)

    View source

Educational content adapted from peptidedosages.com. Not medical advice.